Meet our Team

Matthew P. Jacobson, Ph.D.
Co-Founder

David J. Earp, J.D., Ph.D.
President & CEO

David C. Spellmeyer, Ph.D.
Chief Scientific Officer

Pablo D. Garcia, Ph.D.
Director, Oncology Research

Siegfried S.F. Leung, Ph.D.
Senior Computational Scientist

Cayla M. McEwen
Operations Manager

Andrew T. Bockus, Ph.D.
Scientist II, Chemistry

Catherine Gleason, Ph.D.
Scientist I, Cell Biology

Luis Hernandez
Sr. Research Associate

Breena Walton
Sr. Research Associate

Miles W. Membreno
Research Associate

Miguel P. Baldomero
Research Associate

Bryan M. Lent
Research Associate

Frances Hamkins-Indik
Research Associate

Board of Directors

John Josey, Ph.D.
Chairman of the Board

Peter Svennilson, Ph.D.
The Column Group

Thilo Shroeder, Ph.D.
Nextech Invest

Walter H. Moos, Ph.D.
ShangPharma Innovation / Pandect Bioventures

Founders

R. Scott Lokey, Ph.D.
Co-Founder

Key Advisors

Stefan Knapp, Ph.D.
SAB Member
Daniel F. Veber, Ph.D.
SAB Member
Jack Taunton, Ph.D.
SAB Member
Barbara Weber, M.D.
Senior Advisor, Oncology Therapeutics
William Weis, Ph.D.
Advisor
William G. Kaelin, Jr. M.D.
Advisor
Richard Kriwacki, Ph.D.
Advisor
Zaneta Nikolovska –Coleska, Ph.D.
Advisor
Steven Olson, Ph.D.
Advisor
Ronald Zuckerman, Ph.D.
Advisor
Seth Rubin, Ph.D.
Advisor